Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection
Key facts
- Who runs it
- Sichuan Provincial People's Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 10 people, planned
- Started
- 20 Jul 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Treatments tested
- transanal fecal bacteria transplant
- Record updated
- 15 July 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- 1. Ages 18-70
- 2. Hp infection treatment failed ≥4 times with guidelines-recommended therapies
- 3. Patients with early gastric cancer, peptic ulcer, gastric MALT lymphoma, atrophic gastritis and other diseases requiring the eradication of Hp
Who cannot take part
- 1. Antibiotics and bismuth were taken within 4 weeks before this treatment; Or had taken PPI, H2 receptor antagonist, P-CAB within 2 weeks prior to treatment
- 3. Those who are allergic to the investigational drugs used in this test or have contraindications
- 4. Participated in other drug trials within 3 months before the treatment of this trial
- 7. Patients with malignant tumors, serious concomitant diseases, severe ulcer bleeding or perforation
- 5. There are other serious diseases that affect the evaluation of this study at the same time, or they cannot correctly express their own complaints and cannot cooperate
- 2. Pregnant or lactating women
- 6. Subjects with dysphagia
- 8. Patients judged by the investigator to be unsuitable for clinical trials
- 9. Those who do not want to sign the informed consent for the study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Helicobacter pylori infection
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.
The group in the trial
- washed microbiotaTreatment being tested
Study on the effect of washed microbiota transplantation on eradication of refractory Helicobacter pylori infection.
Treatment: transanal fecal bacteria transplant
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07704255, who can take part
- Record updated
- 15 July 2026